Published in J Clin Psychopharmacol on October 01, 1996
[Psychotropic drugs and diabetes]. Wien Med Wochenschr (2011) 1.40
Viral infection, inflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.96
Preoperative cerebrospinal fluid cytokine levels and the risk of postoperative delirium in elderly hip fracture patients. J Neuroinflammation (2013) 0.95
Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. Psychopharmacology (Berl) (2004) 0.87
Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? Psychopharmacology (Berl) (2015) 0.84
Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions. Neuropsychopharmacology (2016) 0.83
Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication. Neuropsychiatr Dis Treat (2005) 0.82
The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology. Curr Neuropharmacol (2008) 0.82
Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia. Psychopharmacology (Berl) (2013) 0.81
Altered monocyte activation markers in Tourette's syndrome: a case-control study. BMC Psychiatry (2012) 0.79
Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia. J Neural Transm (Vienna) (2009) 0.76
Serial mitogen-stimulated cytokine production from continuously ill patients with schizophrenia. Neuropsychopharmacology (2010) 0.75
Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia. PLoS One (2016) 0.75
Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables. Am J Geriatr Psychiatry (2016) 0.75
The Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their Therapy. Int J Mol Sci (2015) 0.75
Comment on "Eosinophilic gastroenteritis: clinical experience with 15 patients". World J Gastroenterol (2004) 0.75
Clozapine Associated with Autoimmune Reaction, Fever and Low Level Cardiotoxicity - A Case Report. In Vivo (2017) 0.75
Clozapine-induced cardiotoxicity in rats: Involvement of tumour necrosis factor alpha, NF-κβ and caspase-3. Toxicol Rep (2014) 0.75
T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol (1993) 1.74
Diurnal variations in the human host response to endotoxin. J Infect Dis (1996) 1.71
Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy. Sleep Med (2011) 1.50
Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry (2006) 1.38
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res (1999) 1.33
Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J Exp Med (1994) 1.33
Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology (2001) 1.19
Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry (2002) 1.10
Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients. Neuropsychopharmacology (1998) 1.07
Effects of antipsychotic drugs on cytokine networks. J Psychiatr Res (2001) 1.02
Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry (1999) 1.01
Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions. Ann N Y Acad Sci (2001) 0.88
Endotoxin-induced changes in sleep and sleepiness during the day. Psychoneuroendocrinology (1998) 0.87
Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Mol Psychiatry (2010) 0.87
Effects of granulocyte colony-stimulating factor on night sleep in humans. Am J Physiol (1999) 0.86
Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia. Acta Psychiatr Scand (2000) 0.85
In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls. Neurology (1998) 0.85
Sleep during clozapine-induced fever in a schizophrenic patient. Biol Psychiatry (1995) 0.83
Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood (1996) 0.83
Effects of clozapine on sleep: a longitudinal study. Biol Psychiatry (1997) 0.83
A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry (2000) 0.83
Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol. Am J Psychiatry (1997) 0.82
Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep-behavior disorder. J Sleep Res (1999) 0.82
The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels. Pharmacopsychiatry (1997) 0.82
Influence of endotoxin on daytime sleep in humans. Infect Immun (1996) 0.82
Experimental immunomodulation, sleep, and sleepiness in humans. Ann N Y Acad Sci (2000) 0.82
Influence of host defense activation on sleep in humans. Adv Neuroimmunol (1995) 0.81
Impaired circadian waking arousal in narcolepsy-cataplexy. Sleep Res Online (1998) 0.81
Effects of dexamethasone on cytokine plasma levels and white blood cell counts in depressed patients. Psychoneuroendocrinology (2001) 0.79
The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. J Endocrinol (2002) 0.79
Dream self-reflectiveness as a learned cognitive skill. Sleep (1986) 0.78
[On the clinical relevance of clozapine-triggered release of cytokines and soluble cytokine-receptors]. Fortschr Neurol Psychiatr (2001) 0.78
Effects of repeated administration of granulocyte colony-stimulating factor (G-CSF) on neutrophil counts, plasma cytokine, and cytokine receptor levels. Cytokine (1996) 0.78
Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schizophr Res (2000) 0.77
Smoking affects plasma-soluble interleukin-2 receptor levels in patients with schizophrenia. Arch Gen Psychiatry (1997) 0.77
Changes in dehydroepiandrosterone (DHEA) and DHEA-sulfate plasma levels during experimental endotoxinemia in healthy volunteers. J Clin Endocrinol Metab (2000) 0.77
Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors. Arch Gen Psychiatry (1995) 0.76
Salmonella abortus equi endotoxin does not affect leptin plasma levels in healthy humans. J Infect Dis (1999) 0.76
Clozapine-induced parotitis: an immunological cause? Am J Psychiatry (1996) 0.75
[Exacerbation of tics by prednisolone]. Nervenarzt (1998) 0.75
Chronobiological aspects of narcolepsy. Sleep (1994) 0.75
Factors confounding studies of circulating soluble interleukin-2 receptor levels in schizophrenia. Schizophr Res (1998) 0.75
[The physiopathology of weight regulation during treatment with psychotropic drugs]. Fortschr Neurol Psychiatr (2001) 0.75
REM sleep disinhibition at sleep onset: a comparison between narcolepsy and depression. Biol Psychiatry (1997) 0.75
[Zolpidem: the risk of tolerance and dependence according to case reports, systematic studies and recent molecularbiological data]. Fortschr Neurol Psychiatr (2001) 0.75
[Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness]. Nervenarzt (2004) 0.75
[Clozapine, cytokines, fever and sleep]. Wien Med Wochenschr (1996) 0.75
Characterization of the sigma ligand panamesine, a potential antipsychotic, by immune response in patients with schizophrenia and by sleep-EEG changes in normal controls. Psychopharmacology (Berl) (1999) 0.75